- Corona Remedies IPO Day 1 LIVE: Issue booked 38% so far; GMP, subscription status, review, other details. Apply or not?  livemint.com
- CORONA Remedies IPO: Should you apply?  Value Research
- Corona Remedies IPO Day 1: Issue subscribed 42% till now, GMP rises to ₹298 – should you subscribe?  livemint.com
- Corona Remedies IPO GMP: Initial public offering now open for subscription, check grey market premium  India TV News
- Pharma firm Corona Remedies mobilises ₹195 crore from anchor investors, days before initial share-sale opening for public subscription  MSN
​Corona Remedies IPO Day 1 LIVE: Issue booked 38% so far; GMP, subscription status, review, other details. Apply or not?  livemint.comCORONA Remedies IPO: Should you apply?  Value ResearchCorona Remedies IPO Day 1: Issue subscribed 42% till now, GMP rises to ₹298 – should you subscribe?  livemint.comCorona Remedies IPO GMP: Initial public offering now open for subscription, check grey market premium  India TV NewsPharma firm Corona Remedies mobilises ₹195 crore from anchor investors, days before initial share-sale opening for public subscription  MSN by Soban News (international And National News)